Please use this identifier to cite or link to this item:
Title: IFITM3 and severe influenza virus infection. No evidence of genetic association
Authors: López-Rodríguez, M.
Herrera-Ramos, E.
Solé-Violán, J.
Ruíz-Hernández, J. J. 
Borderías, L.
Horcajada, J.P.
Lerma-Chippirraz, E.
Rajas, O.
Briones, M.
Pérez-González, M. C.
García-Bello, M. A.
López-Granados, E.
Rodríguez De Castro, Felipe Carlos B. 
Rodríguez-Gallego, C. 
UNESCO Clasification: 3201 Ciencias clínicas
3207 Patología
Keywords: Susceptibility
Issue Date: 2016
Journal: European Journal of Clinical Microbiology and Infectious Diseases 
Abstract: Influenza virus infection (IVI) is typically subclinical or causes a self-limiting upper respiratory disease. However, in a small subset of patients IVI rapidly progresses to primary viral pneumonia (PVP) with respiratory failure; a minority of patients require intensive care unit admission. Inherited and acquired variability in host immune responses may influence susceptibility and outcome of IVI. However, the molecular basis of such human factors remains largely elusive. It has been proposed that homozygosity for IFITM3 rs12252-C is associated with a population-attributable risk of 5.4 % for severe IVI in Northern Europeans and 54.3 % for severe H1N1pdm infection in Chinese. A total of 148 patients with confirmed IVI were considered for recruitment; 118 Spanish patients (60 of them hospitalized with PVP) and 246 healthy Spanish individuals were finally included in the statistical analysis. PCR-RFLP was used with confirmation by Sanger sequencing. The allele frequency for rs12252-C was found to be 3.5 % among the general Spanish population. We found no rs12252-C homozygous individuals in our control group. The only Spanish patient homozygous for rs12252-C had a neurological disorder (a known risk factor for severe IVI) and mild influenza. Our data do not suggest a role of rs12252-C in the development of severe IVI in our population. These data may be relevant to recognize whether patients homozygous for rs12252-C are at risk of severe influenza, and hence require individualized measures in the case of IVI.
ISSN: 0934-9723
DOI: 10.1007/s10096-016-2732-7
Source: European Journal of Clinical Microbiology and Infectious Diseases [ISSN 0934-9723], v. 35 (11), p. 1811-1817
Appears in Collections:Artículos
Show full item record


checked on Feb 21, 2021


checked on Feb 21, 2021

Page view(s)

checked on Feb 28, 2021

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.